NCT02594332View on ClinicalTrials.gov

Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study

PHASE3TerminatedINTERVENTIONAL

Enrollment

29

Participants

Timeline

Start Date

November 17, 2015

Primary Completion Date

May 22, 2017

Study Completion Date

May 22, 2017

Conditions

Asthma

Interventions

DRUG

Mepolizumab

100 mg SC every 4 weeks for 13 injections

DRUG

Placebo

Trial Locations (1)

55131

Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Pneumologie, Mainz

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Johannes Gutenberg University Mainz

OTHER

NCT02594332 - Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study | Biotech Hunter | Biotech Hunter